Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
Thoracic Cancer|March 11, 2025
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural MesotheliomaBerta Mosleh, Stefan Schwarz, Anna Cho, et al.
British Journal of Cancer|September 4, 2025
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesotheliomaKarin Schelch, Nadine Maach, Muhammad Hashim, et al.
Pathology Oncology Research : POR|June 28, 2020
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell LineLuca Hegedűs, Dominika Rittler, Tamás Garay, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2025
Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancerZewen Jiang, David Haberl, Clemens Spielvogel, et al.
JHLT Open|October 13, 2025
CD38-targeted therapy with Daratumumab in clinical lung transplantation: A single-center experienceCaroline Hillebrand, Giuseppe Maggioni, Sophia Auner, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improveNika Guberina, Christoph Pöttgen, Martin Schuler, et al.
Biomarker Research|June 26, 2026
Spatial transcriptomics reveals compartment-specific cytotoxic T cell crosstalk with AT2 and goblet cells in advanced COPDAyu Hutami Syarif, Bernhard F E Reiter, Alexander Avian, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2020
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma modelPaul Stockhammer, Cassandra Su Lyn Ho, Luca Hegedus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 13, 2014
Extracorporeal CO2 removal as bridge to lung transplantation in life-threatening hypercapniaPeter Schellongowski, Katharina Riss, Thomas Staudinger, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2020
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancerTimm M Reissig, Linda Sara, Saskia Ting, et al.
Pageof 27